Healthcare / Health Information ServicesHelsinki
$1.85
+0.02 (+0.98%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-14.1M · quality 73.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
36/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$62M
P/E
4.5x
↓EV/EBITDA
N/A
•ROE
-74.3%
↓Gross Margin
73.4%
↑Debt/Equity
0.42
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+30.1%
FCF CAGR
—
FCF margin
-402.9%
FCF / Net income
1.12x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $3.5M · net income $-12.7M · FCF $-14.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.5M | $3.5M | $2.9M | $2.4M | $1.6M |
| Net Income | $-12.7M | $-12.7M | $-11.9M | $-12.9M | $-12.2M |
| EBITDA | $-7.0M | $-7.0M | $-7.5M | $-9.6M | $-9.8M |
| EPS | 0.41 | 0.41 | -0.43 | -0.50 | -0.47 |
| Gross Margin | 73.4% | 73.4% | 78.9% | 80.6% | 64.5% |
| Operating Margin | -316.4% | -316.4% | -427.6% | -537.6% | -744.9% |
| Net Margin | -358.3% | -358.3% | -418.9% | -539.0% | -756.9% |
| Balance Sheet | |||||
| Debt/Equity | 0.42 | 0.42 | 0.40 | 0.33 | 0.13 |
| Current Ratio | 3.09 | 3.09 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-14.2M | $-14.2M | $-13.4M | $-14.1M | $-15.2M |
| Returns | |||||
| ROE | -74.3% | -74.3% | -72.1% | -72.2% | -41.5% |
| Valuation | |||||
| P/E | 4.51 | 4.51 | — | — | — |
| P/B | 3.32 | 3.32 | 5.99 | 5.09 | 2.99 |
| Growth & Yield | |||||
| Revenue Growth | 23.9% | 23.9% | 18.9% | 49.3% | — |
| EPS Growth | 195.3% | 195.3% | 14.0% | -6.4% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-26.3%
EPS terminal req.
$0.16
Spread vs growth
221.7%
5Y implied EPS CAGR
-13.5%
EPS terminal req.
$0.20
Spread vs growth
208.9%
10Y implied EPS CAGR
-2.5%
EPS terminal req.
$0.32
Spread vs growth
197.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-45.3%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.43 → 0.41
Residual
-45.3%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.